Oncology

As of March 1st, 2025, Eurobio Scientific Group has successfully completed the acquisition of Quimark SRL, our trusted distributor of 𝐄𝐧𝐝𝐨𝐏𝐫𝐞𝐝𝐢𝐜𝐭® and 𝐏𝐫𝐨𝐥𝐚𝐫𝐢𝐬® in Italy. This strategic step strengthens our presence in the Italian market and reaffirms our commitment to providing innovative oncology solutions to patients and healthcare professionals. We look forward to this new […]

Eurobio Scientific has signed a strategic agreement with Biovica, a company specializing in cancer monitoring, to distribute DiviTum® TKa in key European markets, including DACH, UK, FR and Benelux. This collaboration covers 60% of the European market potential and strengthens Eurobio Scientific’s oncology diagnostics offering. DiviTum® TKa is a blood-based biomarker test that monitors and predicts